drug · small molecule
alisertib
Phase 2updated 3mo agoby $PBYI PUMA BIOTECHNOLOGY, INC.🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 19 investigational indications.
targets
Aurora kinase A
all catalysts(0)
nothing on the calendar yet
Trials studying alisertib
- phase2A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
- phase2Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors
- phase2A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC)
- phase2A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- phase2Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
- phase1Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
- phase2Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer
- phase1Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 35m ago
Found something off?
comments(0)
5-min edit window · permanent after that